Literature DB >> 7969971

Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy.

M Hajek1, H G Wieser, N Khan, A Antonini, P R Schrott, P Maguire, H F Beer, K L Leenders.   

Abstract

We have studied 25 patients with interictal 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) before and after selective surgery for temporal lobe epilepsy (TLE). Based on the findings of the presurgical evaluation, including ictal intracranial EEGs, histopathologic findings, and the postoperative outcome, we classified the patients in three subgroups: (1) patients with TLE of lateral temporal origin (n = 5), (2) patients with mesiobasal limbic TLE associated with mesial gliosis (n = 14), and (3) patients with mesiobasal limbic TLE and small mesial tumors (n = 6). Postoperatively, patients with mesiobasal limbic TLE and mesial gliosis and five of six patients with mesiobasal limbic TLE and mesial tumors were seizure-free; the remaining sixth patient had one generalized seizure. Patients with TLE of lateral temporal origin had more than 90% reduction of seizure frequency. The main postoperative metabolic findings were as follows: (1) marked increase of regional cerebral metabolic rate of glucose (rCMRglu), both in the ipsilateral and, significantly, in the contralateral hemisphere in patients with mesiobasal limbic TLE and mesial gliosis-the changes of brain metabolism were characteristic for patients with the syndrome of "mesial temporal lobe epilepsy" (MTLE); (2) decrease of rCMRglu values in the contralateral mesiobasal temporal lobe (TL) cortex in all patient groups--the reduction of rCMRglu in homologous brain structures contralateral to the operated side provides evidence for stronger interhemispheric connections between both mesial TL structures than were hitherto supposed; and (3) a trend toward a normalization of rCMRglu values in the ipsilateral temporal neocortex 12 months after surgery in patients with MTLE syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969971     DOI: 10.1212/wnl.44.11.2125

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Evolution of lobar abnormalities of cerebral glucose metabolism in 41 children with drug-resistant epilepsy.

Authors:  Tuhina Govil-Dalela; Ajay Kumar; Michael E Behen; Harry T Chugani; Csaba Juhász
Journal:  Epilepsia       Date:  2018-05-22       Impact factor: 5.864

2.  The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy.

Authors:  Beril Gok; George Jallo; Reza Hayeri; Richard Wahl; Nafi Aygun
Journal:  Neuroradiology       Date:  2012-12-08       Impact factor: 2.804

Review 3.  Advances in neuroimaging: management of partial epileptic syndromes.

Authors:  Barbara Schäuble; Gregory D Cascino
Journal:  Neurosurg Rev       Date:  2003-08-22       Impact factor: 3.042

Review 4.  Temporal lobe surgery and memory: Lessons, risks, and opportunities.

Authors:  Kristie Bauman; Orrin Devinsky; Anli A Liu
Journal:  Epilepsy Behav       Date:  2019-11-09       Impact factor: 2.937

5.  Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy.

Authors:  Milo Stanišić; Christopher Coello; Jugoslav Ivanović; Arild Egge; Torsten Danfors; John Hald; Einar Heminghyt; Marjan Makki Mikkelsen; Bård Kronen Krossnes; Are Hugo Pripp; Pål Gunnar Larsson
Journal:  Acta Neurochir (Wien)       Date:  2015-09-08       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.